PRLog - Jan. 29, 2012 - SAN DIEGO -- The announcement by Amgen that it intends to will acquire Micromet for $11 per share prompted an investigation for investors in Micromet Inc. (NASDAQ:MITI)
Investors who purchased shares of Micromet Inc. (NASDAQ:MITI)
The investigations by law firms concern whether Micromet Inc, certain officers and directors, and/or others breached their fiduciary duties to Micromet (NASDAQ: MITI) investors in connection with the proposed acquisition.
On Jan. 26, 2012, Amgen (NASDAQ:AMGN)
However, at least on analyst has set the high target price for NASDAQ:MITI shares at $12 per share, thus above the current offer.
Therefore the investigation for NASDAQ:MITI investors concerns whether the Micromet Board of Directors undertook an adequate sales process and in particular breached their fiduciary duties to Micromet Inc. (NASDAQ:MITI)
Those who are current investors in Micromet Inc. (NASDAQ:MITI)
# # #
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.